Report Detail
Global Anti - Neoplastic Agents Market Insights and Forecast to 2026
- RnM4132757 |
- 13 August, 2020 |
- Global |
- 146 Pages |
- QYResearch |
- Pharma & Healthcare
Anti - Neoplastic Agents market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti - Neoplastic Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti - Neoplastic Agents market is segmented into
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Segment by Application, the Anti - Neoplastic Agents market is segmented into
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
Regional and Country-level Analysis
The Anti - Neoplastic Agents market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti - Neoplastic Agents market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti - Neoplastic Agents Market Share Analysis
Anti - Neoplastic Agents market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti - Neoplastic Agents business, the date to enter into the Anti - Neoplastic Agents market, Anti - Neoplastic Agents product introduction, recent developments, etc.
The major vendors covered:
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
1 Study Coverage
- 1.1 Anti - Neoplastic Agents Product Introduction
- 1.2 Market Segments
- 1.3 Key Anti - Neoplastic Agents Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Anti - Neoplastic Agents Market Size Growth Rate by Type
- 1.4.2 Chemotherapy
- 1.4.3 Targeted Therapy
- 1.4.4 Immunotherapy
- 1.4.5 Hormonal Therapy (Biologic Therapy)
- 1.4.6 Others
- 1.5 Market by Application
- 1.5.1 Global Anti - Neoplastic Agents Market Size Growth Rate by Application
- 1.5.2 Blood Cancer
- 1.5.3 Breast Cancer
- 1.5.4 Gastrointestinal Cancer
- 1.5.5 Prostate Cancer
- 1.5.6 Respiratory/Lung Cancer
- 1.5.7 Other Cancers
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Anti - Neoplastic Agents Market Size, Estimates and Forecasts
- 2.1.1 Global Anti - Neoplastic Agents Revenue 2015-2026
- 2.1.2 Global Anti - Neoplastic Agents Sales 2015-2026
- 2.2 Global Anti - Neoplastic Agents, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Anti - Neoplastic Agents Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Anti - Neoplastic Agents Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti - Neoplastic Agents Competitor Landscape by Players
- 3.1 Anti - Neoplastic Agents Sales by Manufacturers
- 3.1.1 Anti - Neoplastic Agents Sales by Manufacturers (2015-2020)
- 3.1.2 Anti - Neoplastic Agents Sales Market Share by Manufacturers (2015-2020)
- 3.2 Anti - Neoplastic Agents Revenue by Manufacturers
- 3.2.1 Anti - Neoplastic Agents Revenue by Manufacturers (2015-2020)
- 3.2.2 Anti - Neoplastic Agents Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Anti - Neoplastic Agents Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Anti - Neoplastic Agents Revenue in 2019
- 3.2.5 Global Anti - Neoplastic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Anti - Neoplastic Agents Price by Manufacturers
- 3.4 Anti - Neoplastic Agents Manufacturing Base Distribution, Product Types
- 3.4.1 Anti - Neoplastic Agents Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Anti - Neoplastic Agents Product Type
- 3.4.3 Date of International Manufacturers Enter into Anti - Neoplastic Agents Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Anti - Neoplastic Agents Market Size by Type (2015-2020)
- 4.1.1 Global Anti - Neoplastic Agents Sales by Type (2015-2020)
- 4.1.2 Global Anti - Neoplastic Agents Revenue by Type (2015-2020)
- 4.1.3 Anti - Neoplastic Agents Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Anti - Neoplastic Agents Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Anti - Neoplastic Agents Sales Forecast by Type (2021-2026)
- 4.2.2 Global Anti - Neoplastic Agents Revenue Forecast by Type (2021-2026)
- 4.2.3 Anti - Neoplastic Agents Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Anti - Neoplastic Agents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Anti - Neoplastic Agents Market Size by Application (2015-2020)
- 5.1.1 Global Anti - Neoplastic Agents Sales by Application (2015-2020)
- 5.1.2 Global Anti - Neoplastic Agents Revenue by Application (2015-2020)
- 5.1.3 Anti - Neoplastic Agents Price by Application (2015-2020)
- 5.2 Anti - Neoplastic Agents Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Anti - Neoplastic Agents Sales Forecast by Application (2021-2026)
- 5.2.2 Global Anti - Neoplastic Agents Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Anti - Neoplastic Agents Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Anti - Neoplastic Agents by Country
- 6.1.1 North America Anti - Neoplastic Agents Sales by Country
- 6.1.2 North America Anti - Neoplastic Agents Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Anti - Neoplastic Agents Market Facts & Figures by Type
- 6.3 North America Anti - Neoplastic Agents Market Facts & Figures by Application
7 Europe
- 7.1 Europe Anti - Neoplastic Agents by Country
- 7.1.1 Europe Anti - Neoplastic Agents Sales by Country
- 7.1.2 Europe Anti - Neoplastic Agents Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Anti - Neoplastic Agents Market Facts & Figures by Type
- 7.3 Europe Anti - Neoplastic Agents Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Anti - Neoplastic Agents by Region
- 8.1.1 Asia Pacific Anti - Neoplastic Agents Sales by Region
- 8.1.2 Asia Pacific Anti - Neoplastic Agents Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Anti - Neoplastic Agents Market Facts & Figures by Type
- 8.3 Asia Pacific Anti - Neoplastic Agents Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Anti - Neoplastic Agents by Country
- 9.1.1 Latin America Anti - Neoplastic Agents Sales by Country
- 9.1.2 Latin America Anti - Neoplastic Agents Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Anti - Neoplastic Agents Market Facts & Figures by Type
- 9.3 Central & South America Anti - Neoplastic Agents Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Anti - Neoplastic Agents by Country
- 10.1.1 Middle East and Africa Anti - Neoplastic Agents Sales by Country
- 10.1.2 Middle East and Africa Anti - Neoplastic Agents Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Anti - Neoplastic Agents Market Facts & Figures by Type
- 10.3 Middle East and Africa Anti - Neoplastic Agents Market Facts & Figures by Application
11 Company Profiles
- 11.1 Roche
- 11.1.1 Roche Corporation Information
- 11.1.2 Roche Description and Business Overview
- 11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Roche Anti - Neoplastic Agents Products Offered
- 11.1.5 Roche Related Developments
- 11.2 Novartis
- 11.2.1 Novartis Corporation Information
- 11.2.2 Novartis Description and Business Overview
- 11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Novartis Anti - Neoplastic Agents Products Offered
- 11.2.5 Novartis Related Developments
- 11.3 Celgene
- 11.3.1 Celgene Corporation Information
- 11.3.2 Celgene Description and Business Overview
- 11.3.3 Celgene Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Celgene Anti - Neoplastic Agents Products Offered
- 11.3.5 Celgene Related Developments
- 11.4 Bristol-Myers Squibb
- 11.4.1 Bristol-Myers Squibb Corporation Information
- 11.4.2 Bristol-Myers Squibb Description and Business Overview
- 11.4.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Bristol-Myers Squibb Anti - Neoplastic Agents Products Offered
- 11.4.5 Bristol-Myers Squibb Related Developments
- 11.5 Amgen
- 11.5.1 Amgen Corporation Information
- 11.5.2 Amgen Description and Business Overview
- 11.5.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Amgen Anti - Neoplastic Agents Products Offered
- 11.5.5 Amgen Related Developments
- 11.6 Johnson & Johnson
- 11.6.1 Johnson & Johnson Corporation Information
- 11.6.2 Johnson & Johnson Description and Business Overview
- 11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Johnson & Johnson Anti - Neoplastic Agents Products Offered
- 11.6.5 Johnson & Johnson Related Developments
- 11.7 Pfizer
- 11.7.1 Pfizer Corporation Information
- 11.7.2 Pfizer Description and Business Overview
- 11.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Pfizer Anti - Neoplastic Agents Products Offered
- 11.7.5 Pfizer Related Developments
- 11.8 Takeda
- 11.8.1 Takeda Corporation Information
- 11.8.2 Takeda Description and Business Overview
- 11.8.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Takeda Anti - Neoplastic Agents Products Offered
- 11.8.5 Takeda Related Developments
- 11.9 Eli Lilly
- 11.9.1 Eli Lilly Corporation Information
- 11.9.2 Eli Lilly Description and Business Overview
- 11.9.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Eli Lilly Anti - Neoplastic Agents Products Offered
- 11.9.5 Eli Lilly Related Developments
- 11.10 AstraZeneca
- 11.10.1 AstraZeneca Corporation Information
- 11.10.2 AstraZeneca Description and Business Overview
- 11.10.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 AstraZeneca Anti - Neoplastic Agents Products Offered
- 11.10.5 AstraZeneca Related Developments
- 11.1 Roche
- 11.1.1 Roche Corporation Information
- 11.1.2 Roche Description and Business Overview
- 11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Roche Anti - Neoplastic Agents Products Offered
- 11.1.5 Roche Related Developments
- 11.12 Merck & Co.
- 11.12.1 Merck & Co. Corporation Information
- 11.12.2 Merck & Co. Description and Business Overview
- 11.12.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Merck & Co. Products Offered
- 11.12.5 Merck & Co. Related Developments
- 11.13 Sanofi
- 11.13.1 Sanofi Corporation Information
- 11.13.2 Sanofi Description and Business Overview
- 11.13.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Sanofi Products Offered
- 11.13.5 Sanofi Related Developments
- 11.14 Bayer
- 11.14.1 Bayer Corporation Information
- 11.14.2 Bayer Description and Business Overview
- 11.14.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Bayer Products Offered
- 11.14.5 Bayer Related Developments
- 11.15 Biogen Idec
- 11.15.1 Biogen Idec Corporation Information
- 11.15.2 Biogen Idec Description and Business Overview
- 11.15.3 Biogen Idec Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Biogen Idec Products Offered
- 11.15.5 Biogen Idec Related Developments
- 11.16 Eisai
- 11.16.1 Eisai Corporation Information
- 11.16.2 Eisai Description and Business Overview
- 11.16.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Eisai Products Offered
- 11.16.5 Eisai Related Developments
- 11.17 Teva
- 11.17.1 Teva Corporation Information
- 11.17.2 Teva Description and Business Overview
- 11.17.3 Teva Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 Teva Products Offered
- 11.17.5 Teva Related Developments
- 11.18 Otsuka
- 11.18.1 Otsuka Corporation Information
- 11.18.2 Otsuka Description and Business Overview
- 11.18.3 Otsuka Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 Otsuka Products Offered
- 11.18.5 Otsuka Related Developments
- 11.19 Merck KGaA
- 11.19.1 Merck KGaA Corporation Information
- 11.19.2 Merck KGaA Description and Business Overview
- 11.19.3 Merck KGaA Sales, Revenue and Gross Margin (2015-2020)
- 11.19.4 Merck KGaA Products Offered
- 11.19.5 Merck KGaA Related Developments
- 11.20 Ipsen
- 11.20.1 Ipsen Corporation Information
- 11.20.2 Ipsen Description and Business Overview
- 11.20.3 Ipsen Sales, Revenue and Gross Margin (2015-2020)
- 11.20.4 Ipsen Products Offered
- 11.20.5 Ipsen Related Developments
- 11.21 AbbVie
- 11.21.1 AbbVie Corporation Information
- 11.21.2 AbbVie Description and Business Overview
- 11.21.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
- 11.21.4 AbbVie Products Offered
- 11.21.5 AbbVie Related Developments
- 11.22 Gilead Sciences
- 11.22.1 Gilead Sciences Corporation Information
- 11.22.2 Gilead Sciences Description and Business Overview
- 11.22.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
- 11.22.4 Gilead Sciences Products Offered
- 11.22.5 Gilead Sciences Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Anti - Neoplastic Agents Market Estimates and Projections by Region
- 12.1.1 Global Anti - Neoplastic Agents Sales Forecast by Regions 2021-2026
- 12.1.2 Global Anti - Neoplastic Agents Revenue Forecast by Regions 2021-2026
- 12.2 North America Anti - Neoplastic Agents Market Size Forecast (2021-2026)
- 12.2.1 North America: Anti - Neoplastic Agents Sales Forecast (2021-2026)
- 12.2.2 North America: Anti - Neoplastic Agents Revenue Forecast (2021-2026)
- 12.2.3 North America: Anti - Neoplastic Agents Market Size Forecast by Country (2021-2026)
- 12.3 Europe Anti - Neoplastic Agents Market Size Forecast (2021-2026)
- 12.3.1 Europe: Anti - Neoplastic Agents Sales Forecast (2021-2026)
- 12.3.2 Europe: Anti - Neoplastic Agents Revenue Forecast (2021-2026)
- 12.3.3 Europe: Anti - Neoplastic Agents Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Anti - Neoplastic Agents Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Anti - Neoplastic Agents Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Anti - Neoplastic Agents Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Anti - Neoplastic Agents Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Anti - Neoplastic Agents Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Anti - Neoplastic Agents Sales Forecast (2021-2026)
- 12.5.2 Latin America: Anti - Neoplastic Agents Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Anti - Neoplastic Agents Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Anti - Neoplastic Agents Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Anti - Neoplastic Agents Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Anti - Neoplastic Agents Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Anti - Neoplastic Agents Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Anti - Neoplastic Agents Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Anti - Neoplastic Agents Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Anti - Neoplastic Agents. Industry analysis & Market Report on Anti - Neoplastic Agents is a syndicated market report, published as Global Anti - Neoplastic Agents Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Anti - Neoplastic Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
